Advertisement

Local Forearm Vasoconstriction to Endothelin-1 Measured by Venous Occlusion Plethysmography In Vivo

  • Fiona E. Strachan
  • David J. Webb
Protocol
  • 397 Downloads
Part of the Methods in Molecular Biology™ book series (MIMB, volume 206)

Abstract

As a consequence of its potent vasoconstrictor and growth promoting properties, endothelin-1 (ET-1) has been implicated in the pathophysiology of diseases such as hypertension, heart failure and renal failure (1,2). This has lead to the rapid development of endothelin receptor antagonists as potential vasodilator treatments for cardiovascular disease (3), with some of these compounds currently being investigated in clinical trials (4, 5, 6). The previous chapters describe a number of in vitro and in vivo techniques employed in preclinical studies investigating the physiology and pathophysiology of the endothelin system. The current chapter describes the application of venous occlusion plethysmography and local intra-arterial infusion to assess the vascular effects of the endothelin system in healthy volunteers in vivo.

Keywords

Forearm Blood Flow Venous Occlusion Plethysmography Chart Software Baseline Blood Flow Forearm Blood Flow Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Battistini B., Chailler P., D’Orleans Juste P., Briere N., and Sirois P. (1993) Growth regulatory properties of endothelins. Peptides 14, 385–399.PubMedCrossRefGoogle Scholar
  2. 2.
    Haynes W. G. and Webb D. J. (1993) The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin. Sci. 84, 485–500.PubMedGoogle Scholar
  3. 3.
    Strachan F. E. and Webb D. J. (1998) The endothelin system: a novel therapeutic target in cardiovascular disease. Emerging Drugs 3, 95–112.CrossRefGoogle Scholar
  4. 4.
    Freed M. I., Wilson D. E., Thompson K. A., Harris R. Z., Ilson B. E., and Jorkasky D. K. (1999) Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: effects on the regulation of renal vascular tone. Clin. Pharmacol. Ther. 65, 473–482.PubMedCrossRefGoogle Scholar
  5. 5.
    Weber C., Schmitt R., Birnboeck H., Hopfgartner G., vanMarle S. P., Peeters P. A. M., et al. (1996) Pharmacokinetics and pharmacodynamics of the endothelinreceptor antagonist bosentan in healthy human subjects. Clin. Pharmacol. Ther. 60, 124–137.PubMedCrossRefGoogle Scholar
  6. 6.
    Haynes W. G., Ferro C. F., O’Kane K. P. J., Somerville D., Lomax C. C., and Webb D. J. (1996) Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93, 1860–1870.PubMedGoogle Scholar
  7. 7.
    Webb D. J. (1995) The pharmacology of human blood vessels in vivo. J. Vasc. Res. 32, 2–15.PubMedCrossRefGoogle Scholar
  8. 8.
    Clarke J. G., Benjamin N., Larkin S. W., Webb D. J., Davies G. J., and Maseri A. (1989) Endothelin is a potent long-lasting vasoconstrictor in men. Am. J. Physiol. 257, H2033–H2035.PubMedGoogle Scholar
  9. 9.
    Haynes W. G., Strachan F. E., and Webb D. J. (1995) Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92, 357–363.PubMedGoogle Scholar
  10. 10.
    Haynes W. G. and Webb D. J. (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344, 852–854.PubMedCrossRefGoogle Scholar
  11. 11.
    Ferro C. J., Haynes W. G., Johnston N. R., Lomax C. C., Newby D. E., and Webb D.J. (1997) The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction. Br. J. Clin. Pharmacol. 44, 377–383.PubMedCrossRefGoogle Scholar
  12. 12.
    Verhaar M. C., Strachan F. E., Newby D. E., Cruden N. L., Koomans H. A., Rabelink T. J., and Webb D. J. (1998) Endothelin-A receptor antagonist mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97, 752–756.PubMedGoogle Scholar
  13. 13.
    Hand M. F., Haynes W. G., and Webb D. J. (1999) Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure. Kidney Int. 55, 613–620.PubMedCrossRefGoogle Scholar
  14. 14.
    Love M. P., Haynes W. G., Gray G. A., Webb D. J., and McMurray J. J. (1996) Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation 94, 2131–2137.PubMedGoogle Scholar
  15. 15.
    Strachan F., Newby D., Sciberras D., McCrea J., Goldberg M., and Webb D. (1998) Reproducibility of forearm vasoconstriction to intra-arterial endothelin-1. Br. J. Clin. Pharmacol. 45, 194P–195P.Google Scholar
  16. 16.
    Strachan F. E., Newby D. E., Sciberras D. G., McCrea J. B., Goldberg M. R., and Webb D. J. The effect of the nonselective endothelin receptor antagonist L-753,037 on forearm vasoconstriction to endothelin-1. Br. J. Clin. Pharmacol., in press.Google Scholar
  17. 17.
    Love M. P., Ferro C. J., Haynes W. G., Webb D. J., and McMurray J. J. (1996) Selective or nonselective endothelin receptor blockade in chronic heart failure? Circulation 94, 2899–2900.Google Scholar
  18. 18.
    Kerslake D. M. (1949) The effect of the application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J. Physiol. 108, 451–457.Google Scholar
  19. 19.
    Stroes E. S., Koomans H. A., de Bruin T. W. A., and Rabelink T. J. (1995) Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346, 467–471.PubMedCrossRefGoogle Scholar
  20. 20.
    Haynes W. G. and Webb D. J. (1993) Endothelium dependent modulation of responses to endothelin-1 in human veins. Clin. Sci. 84, 427–433.PubMedGoogle Scholar
  21. 21.
    Kiowski W., Luscher T. F., Linder L., and Buhler F. R. (1991) Endothelin-1 induced vasoconstriction in humans: reversal by calcium-channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83, 469–475.PubMedGoogle Scholar
  22. 22.
    Wiinberg N., Walter-Larson S., Eriksen C., and Nielsen P. E. (1988) An evaluation of semi-automatic blood pressure manometers against intra-arterial blood pressure. J. Ambulatory Monitoring 1, 303–309.Google Scholar
  23. 23.
    Patterson G. C. and Shepherd J. T. (1954) The blood flow in the human forearm following venous congestion. J. Physiol. (Lond) 125, 501–507.Google Scholar

Copyright information

© Humana Press Inc. 2002

Authors and Affiliations

  • Fiona E. Strachan
    • 1
  • David J. Webb
    • 2
  1. 1.Scottish Poisons Information BureauLothian University Hospital NHS TrustEdinburghUK
  2. 2.Clinical Pharmacology Unit and Research CentreUniversity of Edinburgh, Western General HospitalEdinburghUK

Personalised recommendations